CBP/p300 and muscle differentiation: no HAT, no muscle.

Abstract

Terminal differentiation of muscle cells follows a precisely orchestrated program of transcriptional regulatory events at the promoters of both muscle-specific and ubiquitous genes. Two distinct families of transcriptional co-activators, GCN5/PCAF and CREB-binding protein (CBP)/p300, are crucial to this process. While both possess histone acetyl-transferase (HAT) activity, previous studies have failed to identify a requirement for CBP/p300 HAT function in myogenic differentiation. We have addressed this issue directly using a chemical inhibitor of CBP/p300 in addition to a negative transdominant mutant. Our results clearly demonstrate that CBP/p300 HAT activity is critical for myogenic terminal differentiation. Furthermore, this requirement is restricted to a subset of events in the differentiation program: cell fusion and specific gene expression. These data help to define the requirements for enzymatic function of distinct coactivators at different stages of the muscle cell differentiation program.

Statistics

01020'03'05'07'09'11'13'15'17
Citations per Year

57 Citations

Semantic Scholar estimates that this publication has 57 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Polesskaya2001CBPp300AM, title={CBP/p300 and muscle differentiation: no HAT, no muscle.}, author={Anna Polesskaya and Irina Naguibneva and Lauriane Fritsch and Arnaud Duquet and Slimane Ait-Si-Ali and Ph Robin and Arlette Vervisch and Linda Louise Pritchard and Philip A. Cole and Annick Harel-Bellan}, journal={The EMBO journal}, year={2001}, volume={20 23}, pages={6816-25} }